RxDoctor Payments Data

Chelcia Wright, APRN

Family · Oak Grove, KYNPI 1053702282

Payments from drug & device makers

$681in general payments, 2019–2025

Across 24 payments — averaging $28.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paratek Pharmaceuticals, Inc.$125
  • Phathom Pharmaceuticals, Inc.$121
  • Novartis$75
  • Upsher-smith Laboratories LLC$73
  • Johnson & Johnson$59
  • Exact Sciences$49
  • plus $179 from 7 others

What the payments were for

  • Food & beverage$681100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$681 in reported general payments places this provider in the 55th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$27,262
Medicare patients
54
Services billed
446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban23$29,688
JardianceEmpagliflozin15$18,714
XareltoRivaroxaban23$13,179
TrulicityDulaglutide11$11,400
JanuviaSitagliptin Phosphate14$10,051
Breo ElliptaFluticasone/Vilanterol12$8,215
Losartan Potassium70$1,165
Atorvastatin Calcium139$1,128
Metoprolol Succinate76$979
Lisinopril135$974
Gabapentin39$965
Amlodipine Besylate102$818
Omeprazole30$779
Rosuvastatin Calcium68$771
Metformin Hcl67$651

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$30$18,71415 claims
Johnson & JohnsonXarelto$59$13,17923 claims
Lilly USA, LLCTrulicity$30$11,40011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,374 family providers in Kentucky.

Other family in Oak Grove

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →